ClinConnect ClinConnect Logo
Search / Trial NCT00143598

The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome

Launched by SIR MORTIMER B. DAVIS - JEWISH GENERAL HOSPITAL · Sep 1, 2005

Trial Information

Current as of August 25, 2025

Completed

Keywords

Postphlebitic Syndrome Post Thrombotic Syndrome Elastic Stockings Stockings, Compression Randomized Controlled Trials Quality Of Life

ClinConnect Summary

The post-thrombotic syndrome (PTS) is a frequent, burdensome and costly condition that occurs in about one third of patients after an episode of deep vein thrombosis (DVT). Affected patients have chronic leg pain and swelling, and sometimes develop skin ulcers. At present, there is little to offer for the treatment of this condition. Prevention of PTS is the key to reducing its burden on patients and society. Elastic compression stockings (ECS) could be helpful in preventing PTS, however data on their effectiveness are scarce and conflicting.

Comparison(s): Knee-length, 30-40 mm Hg (Class ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Consecutive patients with a first, symptomatic, objectively confirmed proximal DVT diagnosed within the last 14 days (with or without concurrent distal DVT or pulmonary embolism)
  • Who have no contraindications to standard treatment with heparin and/or warfarin, and
  • Who provide informed consent to participate
  • Exclusion Criteria:
  • Contraindication to compression stockings
  • Limited lifespan (estimated \< 6 months)
  • Geographic inaccessibility preventing return for follow-up visits
  • Inability to apply stockings daily and unavailability of a caregiver to apply stockings daily
  • Treatment of acute DVT with thrombolytic agents

About Sir Mortimer B. Davis Jewish General Hospital

Sir Mortimer B. Davis – Jewish General Hospital is a leading academic medical center located in Montreal, Canada, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical research, the hospital integrates cutting-edge scientific inquiry with comprehensive patient care, focusing on a range of medical disciplines to enhance treatment outcomes and improve patient quality of life. With a strong emphasis on collaboration, ethics, and community engagement, the hospital strives to foster a research environment that promotes discovery and translates findings into effective therapeutic solutions.

Locations

Durham, North Carolina, United States

Montreal, Quebec, Canada

Winnipeg, Manitoba, Canada

London, Ontario, Canada

Oklahoma City, Oklahoma, United States

Montreal, Quebec, Canada

Toronto, Ontario, Canada

Toronto, Ontario, Canada

Victoria, British Columbia, Canada

Detroit, Michigan, United States

Halifax, Nova Scotia, Canada

Hamilton, Ontario, Canada

Hamilton, Ontario, Canada

Hamilton, Ontario, Canada

Hamilton, Ontario, Canada

Hamilton, Ontario, Canada

Ottawa, Ontario, Canada

Longueuil, Quebec, Canada

Montreal, Quebec, Canada

Montreal, Quebec, Canada

Montreal, Quebec, Canada

Montreal, Quebec, Canada

Montreal, Quebec, Canada

Montreal, Quebec, Canada

Quebec City, Quebec, Canada

Patients applied

0 patients applied

Trial Officials

Susan R. Kahn, M.D., M.Sc.

Principal Investigator

Sir Mortimer B. Davis - Jewish General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials